- Home
- FBIO vs MCN Comparison
FBIO vs MCN Comparison
Compare FBIO & MCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBIO | MCN |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | United States | Canada |
| Employees | 78 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.6M | 127.0M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | FBIO | MCN |
|---|---|---|
| Price | $3.37 | $5.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 611.0K | 73.7K |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.96% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $55.22 | N/A |
| Revenue Next Year | $40.55 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.77 | $5.46 |
| 52 Week High | $4.53 | $6.39 |
Technical Indicators
Market Signals| Indicator | FBIO | MCN |
|---|---|---|
| Relative Strength Index (RSI) | 58.98 | 43.57 |
| Support Level | $3.28 | N/A |
| Resistance Level | $3.80 | $6.02 |
| Average True Range (ATR) | 0.22 | 0.05 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 59.46 | 56.48 |
Price Performance
Historical ComparisonAbout FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
About MCN Madison Covered Call & Equity Strategy Fund
XAI Madison Equity Premium Income Fund is an investment management company. The Fund invests in an actively managed equity portfolio comprised of individual stocks and covered call options. The Fund's primary investment objective is to provide high level of current income and gains, with a secondary objective of capital appreciation.